Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer
1998

Predicting Urothelial Cancer Recurrence with MMP-2 and TIMP-2 Levels

Sample size: 97 publication Evidence: high

Author Information

Author(s): K Gohji, N Fujimoto, J Ohkawa, A Fujii, M Nakajima

Primary Institution: Hyogo Medical Center for Adults

Hypothesis

The serum MMP-2/TIMP-2 ratio can predict the recurrence of urothelial cancer.

Conclusion

An imbalance between serum MMP-2 and TIMP-2 levels is a significant predictor of recurrence in advanced urothelial cancer patients.

Supporting Evidence

  • The serum MMP-2/TIMP-2 ratio was significantly higher in patients with recurrence compared to those without.
  • Patients with high MMP-2/TIMP-2 ratios had poorer disease-free survival rates.
  • Univariate and multivariate analyses showed the MMP-2/TIMP-2 ratio as a significant independent predictor of recurrence.

Takeaway

Doctors can check the levels of certain proteins in the blood to see if a bladder cancer patient might have their cancer come back after treatment.

Methodology

Serum levels of MMP-2 and TIMP-2 were measured in 97 urothelial cancer patients and compared to 127 healthy controls.

Limitations

The study only included patients who underwent complete resection and may not apply to all urothelial cancer patients.

Participant Demographics

97 urothelial cancer patients (44 superficial, 53 advanced) and 127 healthy controls (85 males, 42 females, ages 18-69).

Statistical Information

P-Value

P = 0.0029

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication